Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $4.97 USD
Change Today -0.03 / -0.60%
Volume 306.9K
BTX On Other Exchanges
BTX is not on other exchanges.
As of 6:40 PM 03/31/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Robert W. Peabody CPA

Chief Financial Officer, Principal Accounting Officer and Senior Vice President, BioTime, Inc.
AgeTotal Calculated CompensationThis person is connected to 17 board members in 3 different organizations across 7 different industries.

See Board Relationships
As of Fiscal Year 2013


Mr. Robert W. Peabody, CPA has been the Chief Financial Officer of Asterias Biotherapeutics, Inc. since June 2013 and serves as its Principal Accounting Officer. Mr. Peabody serves as the Chief Operating Officer of ES Cell International Pte Ltd. He has been a Senior Vice President of BioTime, Inc. since October 2007 and as its Chief Financial Officer since May 10, 2013. He serves as an Advisor at LifeMap Sciences, Inc. He served as the Chief Operating Officer of BioTime, ...

Read Full Background

Corporate Headquarters*

1301 Harbor Bay Parkway
Alameda, California 94502

United States

Phone: 510-521-3390
Fax: 510-521-3389

Board Members Memberships*

Chief Operating Officer and Director
Former Vice President of Grant Administration
Former Vice President of Grant Administration and Director
Executive Officer and Director
Chief Financial Officer, Principal Accounting Officer and Director


University of Michigan

Other Affiliations*

Annual Compensation*

Total Annual Compensation$550,107

Stock Options*

All Other Compensation$11,984
Exercisable Options1,123,106
Exercisable Options Value$3,134,329
Unexercisable Options424,065
Unexercisable Options Value$742,263
Total Value of Options$3,876,591
Total Number of Options1,547,171

Total Compensation*

Total Annual Cash Compensation$562,091
Total Short Term Compensation$550,107
Other Long Term Compensation$11,984
Total Calculated Compensation$1,083,591
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BTX:US $4.97 USD -0.03


Gil Van Bokkelen Ph.D.Co-Founder, Chairman and Chief Executive Officer
Athersys, Inc.
John A. Scarlett M.D.Chief Executive Officer, President and Director
Geron Corporation
Robert J. Palay MBA, J.D.Founder, Chairman of the Board and Chief Executive Officer
Cellular Dynamics International, Inc.
Yokoyama Chikafumi Ph.D.Chief Executive Officer, President and Representative Director
ReproCELL, Inc.
Keith Murphy Chairman, Chief Executive Officer, President, Member of Audit Committee and Member of Science & Technology Committee
Organovo Holdings, Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIOTIME INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at